Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
6.25
+0.26 (4.34%)
Dec 20, 2024, 4:00 PM EST - Market closed
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $353.88 million as of December 20, 2024. Its market cap has increased by 163.30% in one year.
Market Cap
353.88M
Enterprise Value
102.33M
1-Year Change
163.30%
Ranking
Category
Stock Price
$6.25
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $353.88M, a decrease of -83.96%. That is a compound annual growth rate of -38.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 353.88M | 138.46% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 357.04M |
| Prime Medicine | 355.99M |
| AngioDynamics | 348.64M |
| Kamada | 344.88M |
| Contineum Therapeutics | 344.13M |
| Valneva SE | 337.82M |
| Absci | 335.38M |
| Spok Holdings | 333.68M |